cota-logo-wht-rgb
Contact Us
cota-logo-wht-rgb
cota-pattern

Bringing clarity

We are working to ensure that everyone touched by cancer has a clear path to the right care.
cota-pattern

Our

We combine oncology expertise with advanced technology and analytics to organize real world data in order to guide decisions and actions.

Together, we can bring clarity to cancer care.

#6846 - COTA Healthcare homepage redesign - Providers

Providers

We curate EHR data that can be used to drive research and standardization in order to improve patient outcomes while also reducing costs at your institution.

#6846 - COTA Healthcare homepage redesign - Payers

Payers

We make clinical sense of claims data, providing insight into performance and related outcomes across sites in order to support value-based payment models.

#6846 - COTA Healthcare homepage redesign - Life Sciences

Life Sciences

Our deeply curated real world data accelerates drug development informing the decisions and actions that will deliver the best drugs to patients faster and at a lower cost.

“COTA was founded in 2011 by oncologists, engineers, and data scientists, with one aim in mind: to transform cancer care so that every patient gets the right treatment. That’s not a mission we can achieve alone. We are committed to working with providers, payers, life sciences companies, patients and the FDA to change how cancer is studied and treated.”
Andrew Pecora, M.D. Founder & Chairman
Featured

The Role of Real World Data in Bringing Medication to Market and Beyond with Bruno Villetelle

In this episode of Real World Talk, host Emily Di Capua talks to Bruno Villetelle, Head of Data and Digital for Novartis. They discuss the ways real world data is being used to innovate drug development and delivery so that patients can benefit from new discoveries sooner.
Listen to the episode

Latest

The Lancet Rheumatology Publishes Additional Findings on Tocilizumab, Fueled by Real-World Data

A recent observational study using real world data shows promising results from using tocilizumab in patients with severe COVID-19. According to study co-author Shivam Mathura, “While these results need to be further validated through clinical trials, we are thrilled to provide early insights to those in the field as we continue to fight this pandemic.”
read more

2020 MedTech Breakthrough Awards Recognize COTA as the Best Overall Medical Data Solution Provider

COTA, Inc. is pleased to announce that MedTech Breakthrough has named COTA as a winner in the fourth annual MedTech Breakthrough Awards program for the “Best Overall Medical Data Solution Provider” award.
read more

FDA’s Dr. Amy Abernethy Explains How Real World Data Can Be Used in a Pandemic

“Real-world data can help us understand the story of a disease. It can help us prioritize treatments that might work. It can help us understand and put those treatments into context.”
listen now

Let’s work together to transform cancer care.

REQUEST A DEMO

Bringing clarity

We are working to ensure that everyone touched by cancer has a clear path to the right care.